tirzepatide and kidney disease Renal effects of GLP-1 receptor agonists in individuals with type 2 diabetes: seeds of a promising future | Endocrine Tirzepatide Reduces Progression of Chronic

Calcium Divalent calcium ions (Ca 2+ ) are involved in many aspects of cellular life and death

Since osteoporosis and obesity are two diseases that affect a vast majority of postmenopausal women concomitantly, using a single drug that is Food and Drug Administration (FDA) approved for obesity to prevent and manage both osteoporosis and obesity could improve the quality of life and decrease the complications and medical costs that occur as a result of both diseases

Utilization of citrate, acetyl-carnitine, acetate, pyruvate and glucose for the synthesis of acetylcholine in rat brain slices

Kinetic Optimization in Myogenic Research: Evaluating the Splice-Variant Specificity of IGF-1LR3 and IGF-DES Explore the dynamic differences between IGF-1LR3 and IGF-DES to discover which muscle-healing peptide is right for your unique recovery, fat loss, and performance goals

The data suggest that combining CGM and GLP-1s can lead to greater reductions in A1C among people with type 2 diabetes